Market News AIOpen the app

Catheter Precision shares a study showing its LockeT device works better than Abbott's Perclose device.

MarketRead the original at morningstar.com
Bad for ABT

Abbott's Perclose had more access-site complications and device failures than LockeT in the 172-patient study. Equal timing and discharge results soften the concern, but the worse results weigh against Perclose.

ABT · Abbott Laboratories

AI read · Bad for ABT

The AI's read

That comparison could make Perclose less appealing to hospitals choosing a closure device. Equal results for timing and discharge soften the concern, and one study does not show whether hospitals will switch. Still, the complication and failure results point against Abbott's device.

Get alerts for ABT

Follow Abbott Laboratories (ABT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ABT
Free on the App Store and Google Play, or on the web.